548 Episodes

  1. Crowdsourcing Therapeutic Approaches for an Ultra-Rare Disease

    Published: 2/5/2020
  2. Delivering Oligonucleotide Therapies to Any Cell Type

    Published: 1/29/2020
  3. Protalix Looks Beyond Biobetters

    Published: 1/22/2020
  4. Driving N-of-1 Therapies for Ultra-Rare Disease Patients

    Published: 1/15/2020
  5. Cutting the Time and Cost of Drug Discovery with MicroOrgans

    Published: 1/8/2020
  6. Acquisition Combines Two Pipelines for Rare Skin Diseases

    Published: 1/2/2020
  7. Programming Cells to Produce Neuroprotective Factors to Treat ALS

    Published: 12/26/2019
  8. Origin's Rapid Path to Seek Approval for Treatment of Ultra-Rare Metabolic Condition

    Published: 12/18/2019
  9. Developing a Common Language for Rare Diseases

    Published: 12/11/2019
  10. Why Payers Lag Drug Developers and Regulators in Embracing Real-World Evidence

    Published: 12/4/2019
  11. How a Brother's Love Is Forging a Path for Customized Therapies for Rare Disease Patients

    Published: 11/27/2019
  12. Addressing the Barriers to Accessing Experimental Therapies

    Published: 11/20/2019
  13. A Journey to Advocacy

    Published: 11/13/2019
  14. Turning Chronic Illness into a Fashion Statement

    Published: 11/6/2019
  15. Connecting Young Adults with Rare and Chronic Conditions

    Published: 10/30/2019
  16. Helping Caregivers Care for Themselves

    Published: 10/23/2019
  17. A Festival of Moving Pictures

    Published: 10/16/2019
  18. Deep Genomics Boasts an AI First in Drug Discovery

    Published: 10/9/2019
  19. How to Live with a Disability with Your Mojo Intact

    Published: 10/3/2019
  20. Why a Big Pharma Exec Embraced Rare Neurological Diseases

    Published: 9/25/2019

15 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.